OHIM to crack down on non-payers

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

OHIM to crack down on non-payers

ohim-logo-45.gif

Two changes affecting CTM applicants will come into effect on November 24: OHIM will only examine applications after they have been paid for, and it will also introduce a fast-track procedure

OHIM logo

The first change is driven by the desire to improve efficiency, as the Office will not spend time examining or processing mail for applications where no payment has been made.

At present, CTM applicants can pay the basic fee within one month of filing the application. About 4% of CTM applications are examined but never paid for, and OHIM says that proportion is rising.

The second change means that applications will be published in half the time it takes regular applications, or even less.

To be eligible for the fast track procedure, applicants must (1) select the goods and services from OHIM’s harmonised database and (2) pay at the end of the application process or immediately after submission. Additionally, the application should not trigger any deficiency finding at the time of submission or during examination.

More details are available on OHIM’s website.



more from across site and SHARED ros bottom lb

More from across our site

In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
Gift this article